全血S1PR4 mRNA水平与动脉瘤性蛛网膜下腔出血后脑血管痉挛相关
一项前瞻性转录组研究纳入44例动脉瘤性蛛网膜下腔出血(aSAH)患者,其中发生血管痉挛者22例(VSP+组)、未发生者22例(VSP-组),用Illumina Human HT12v4.0芯片检测全血21,460个mRNA探针;结果显示发生血管痉挛的患者就诊时全血1-磷酸鞘氨醇受体4(S1PR4)mRNA水平显著高于未发生者(p=8.03×10⁻⁶)。
要点
- aSAH后发生血管痉挛者就诊时全血S1PR4 mRNA水平显著高于未发生者(p=8.03×10⁻⁶)。
- 结果与既往动物模型实验研究一致,支持S1PR4及其配体1-磷酸鞘氨醇(S1P)在动脉相关血管收缩中的作用。
- 作者认为S1PR4或可作为aSAH患者脑血管痉挛的生物标志物。
核心结论
- 结果与既往动物模型实验研究一致,支持S1PR4及其配体1-磷酸鞘氨醇(S1P)在动脉相关血管收缩中的作用,提示S1PR4或可作为aSAH患者脑血管痉挛的生物标志物。
研究设计与样本
- 前瞻性转录组研究,纳入44例aSAH患者,发生血管痉挛者22例(VSP+组)、未发生者22例(VSP-组),用Illumina Human HT12v4.0芯片检测全血21,460个mRNA探针,采用线性混合模型进行差异统计分析。
主要发现
- 发生血管痉挛的aSAH患者就诊时全血S1PR4 mRNA水平显著高于未发生血管痉挛者(p=8.03×10⁻⁶)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors sought to identify mRNA biomarkers of cerebral vasospasm in whole blood of patients suffering from aneurysmal subarachnoid hemorrhage (aSAH). METHODS: A prospective transcriptomic study for vasospasm was conducted in whole blood samples of 44 aSAH patients who developed (VSP+ group, n = 22) or did not develop (VSP- group, n = 22) vasospasm. Samples from all patients were profiled for 21,460 mRNA probes using the Illumina Human HT12v4.0 array. Differential statistical analysis was performed using a linear mixed model. RESULTS: Levels of sphingosine-1-phosphate receptor 4 (S1PR4) mRNA were significantly higher (p = 8.03 × 10-6) at presentation in patients who developed vasospasm after aSAH than in patients who did not. CONCLUSIONS: The results, which are consistent with findings of previous experimental investigations conducted in animal models, support the role of S1PR4 and its ligand, sphingosine-1-phosphate (S1P), in arterial-associated vasoconstriction, which suggests that S1PR4 could be used as a biomarker for cerebral vasospasm in aSAH patients.
引用
- Pulcrano-Nicolas AS, Jacquens A, Proust C, et al. Whole blood levels of S1PR4 mRNA associated with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019. PMID: 31783362. doi:10.3171/2019.9.JNS191305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。